Covered recipient · General Payments record
DANIELLE SUDILOVSKY
General Payments · PY2024
$213.29
- Reported across 8 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $213.29 | 8 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ANI Pharmaceuticals, Inc. | $75.91 | 3 |
| Madrigal Pharmaceuticals | $65.45 | 2 |
| Smith & Nephew, Inc. | $29.97 | 1 |
| Otsuka America Pharmaceutical, Inc. | $27.27 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $14.69 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $213.29 | 8 |
Payment records · PY2024 (8)
Sorted by paying entity, then date · as published by CMS
Program year 2024
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ANI Pharmaceuticals, Inc. | $28.13 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091139762 | CMS |
| ANI Pharmaceuticals, Inc. | $25.03 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091137494 | CMS |
| ANI Pharmaceuticals, Inc. | $22.75 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091170676 | CMS |
| Madrigal Pharmaceuticals | $38.39 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144183337 | CMS |
| Madrigal Pharmaceuticals | $27.06 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144183339 | CMS |
| Otsuka America Pharmaceutical, Inc. | $27.27 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118989534 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $14.69 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153483766 | CMS |
| Smith+Nephew, Inc. | $29.97 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149613304 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.